News & Updates

Show Multimedia Only

Deutetrabenazine for tardive dyskinesia yields favourable patient-reported outcomes

24 Jul 2025 by

Individuals with tardive dyskinesia (TD) report favourable outcomes with the VMAT2 inhibitor deutetrabenazine in an age subgroup analysis.

Deutetrabenazine for tardive dyskinesia yields favourable patient-reported outcomes

24 Jul 2025

Early-onset neonatal sepsis ups risk of childhood epilepsy

23 Jul 2025

Infants who contract an invasive bacterial infection during the first week of life have double the risk of epilepsy in childhood, according to a register-based cohort study from Denmark.

Early-onset neonatal sepsis ups risk of childhood epilepsy

23 Jul 2025

GLP-1 RAs show signal of benefit in fibromyalgia

18 Jul 2025 by

New research suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), commonly used for diabetes and obesity, may hold therapeutic potential for patients with fibromyalgia.

GLP-1 RAs show signal of benefit in fibromyalgia

18 Jul 2025

RW study in Chinese migraine patients: Rimegepant effective with high satisfaction rates

18 Jul 2025

Rimegepant as an acute treatment for migraine is effective with high patient satisfaction rates, a real-world (RW) registry study in Chinese patients has shown.

RW study in Chinese migraine patients: Rimegepant effective with high satisfaction rates

18 Jul 2025

Is sildenafil neuroprotective?

14 Jul 2025 by

A systematic review and meta-analysis conducted by researchers from Singapore demonstrates an association between treatment with sildenafil, a phosphodiesterase-5 (PDE5) inhibitor, and the risk of Alzheimer's disease (AD).

Is sildenafil neuroprotective?

14 Jul 2025

CGRP-targeted therapies herald a new era in migraine management

14 Jul 2025 by

Calcitonin gene–related peptide (CGRP)–targeted therapies are likely to become a mainstay of migraine headache treatment in the coming decades as they have demonstrated efficacy for acute and preventive treatment, according to Dr Yi-Jing Zhao of Mount Elizabeth Hospital, Singapore, who spoke at AIM 2025.

CGRP-targeted therapies herald a new era in migraine management

14 Jul 2025

Ambroxol safe but fails to improve cognition in Parkinson’s disease dementia

11 Jul 2025

Treatment with ambroxol in patients with Parkinson’s disease dementia (PDD) is safe and well tolerated but falls short of improving cognition, according to a single-centre phase II study.

Ambroxol safe but fails to improve cognition in Parkinson’s disease dementia

11 Jul 2025

Fibromyalgia linked to lower sexual desire in women

08 Jul 2025

Sexual desire is reduced in women with fibromyalgia, driven primarily by age, time since diagnosis, and depressive symptoms, according to a study.

Fibromyalgia linked to lower sexual desire in women

08 Jul 2025

More cognitive issues, fewer heart problems after COVID-19 vs flu hospitalization in Asians

04 Jul 2025 by

Individuals hospitalized for COVID-19 vs seasonal influenza face a greater risk of cognitive impairment and fatigue but a lower risk of cardiac disorders as long-term consequences of infection, according to a retrospective population-based cohort study in Singapore.

More cognitive issues, fewer heart problems after COVID-19 vs flu hospitalization in Asians

04 Jul 2025

Diagnosing transient loss of consciousness: Approach to a common clinical conundrum

04 Jul 2025 by

Over 90 percent of transient loss of consciousness (TLOC) presentations are due to syncope, seizure or psychogenic causes, but up to 30 percent of them are misdiagnosed initially due to significant overlap in manifestations, according to Dr Charlie Chan of the Prince of Wales Hospital, who shared tips on diagnosis at AIM 2025.

Diagnosing transient loss of consciousness: Approach to a common clinical conundrum

04 Jul 2025

News & Updates

Showing Neurology articles

Showing

Specialty:

Deutetrabenazine for tardive dyskinesia yields favourable patient-reported outcomes

Deutetrabenazine for tardive dyskinesia yields favourable patient-reported outcomes

Early-onset neonatal sepsis ups risk of childhood epilepsy

Early-onset neonatal sepsis ups risk of childhood epilepsy

GLP-1 RAs show signal of benefit in fibromyalgia

GLP-1 RAs show signal of benefit in fibromyalgia

RW study in Chinese migraine patients: Rimegepant effective with high satisfaction rates

RW study in Chinese migraine patients: Rimegepant effective with high satisfaction rates

Is sildenafil neuroprotective?

Is sildenafil neuroprotective?

CGRP-targeted therapies herald a new era in migraine management

CGRP-targeted therapies herald a new era in migraine management

Ambroxol safe but fails to improve cognition in Parkinson’s disease dementia

Ambroxol safe but fails to improve cognition in Parkinson’s disease dementia

Fibromyalgia linked to lower sexual desire in women

Fibromyalgia linked to lower sexual desire in women

More cognitive issues, fewer heart problems after COVID-19 vs flu hospitalization in Asians

More cognitive issues, fewer heart problems after COVID-19 vs flu hospitalization in Asians

Diagnosing transient loss of consciousness: Approach to a common clinical conundrum

Diagnosing transient loss of consciousness: Approach to a common clinical conundrum